Evidence map›Paper›PMID 42448967›Full record

ArticleExperimental & molecular medicine2026

Gut microbiome modulation by Veillonella ratti induces resistance to EAE pathogenesis via microbe-derived metabolites.

Panida Sittipo, Joon-Young Park, Eunike Tiffany, Ara Oh, Subin Moon, Chan Hee Lee, Jae Sang Oh, Tae-Young Kim, Mi-Na Kweon, Jaeseoung Choi and 9 more

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Panida Sittipo *Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Cheonan, Republic of Korea.
Joon-Young Park *Department of Life Science, Multidisciplinary Genome Institute, Hallym University, Chuncheon, Republic of Korea.ORCID http://orcid.org/0000-0002-7077-0807
Eunike Tiffany *Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Cheonan, Republic of Korea.ORCID http://orcid.org/0000-0003-1255-7343
Ara OhDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Cheonan, Republic of Korea.
Subin MoonDepartment of Biomedical Science, Hallym University, Chuncheon, Republic of Korea.
Chan Hee LeeDepartment of Biomedical Science, Hallym University, Chuncheon, Republic of Korea.ORCID http://orcid.org/0000-0001-8791-817X
Jae Sang OhDepartment of Neurosurgery, Uijeongbu St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Tae-Young KimMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.
Mi-Na KweonMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-2916-2524
Jaeseoung ChoiDepartment of Pharmaceutical Engineering, College of Medical Sciences, Soonchunhyang University, Asan, Republic of Korea.
Keon-Hyoung SongDepartment of Pharmaceutical Engineering, College of Medical Sciences, Soonchunhyang University, Asan, Republic of Korea.
Dong-Woo LeeDepartment of Biotechnology, Yonsei University, Seoul, Republic of Korea.
Myung Hee NamMetropolitan Seoul Center, Korea Basic Science Institute (KBSI), Seoul, Republic of Korea.
Soo-Jong HongDepartment of Pediatrics, Humidifier Disinfectant Health Center, National Medical Center, Seoul, Republic of Korea.
Eun-Young LeeDepartment of Biochemistry, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
Seong Ran JeonDigestive Disease Center, Institute for Digestive Research, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.
Ho-Yeon SongDepartment of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
Bong-Soo KimDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul, Republic of Korea. bkim79@ewha.ac.kr.
Yun Kyung LeeDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Cheonan, Republic of Korea. yunklee@sch.ac.kr.ORCID http://orcid.org/0000-0003-3437-5137

Funding

National Research Foundation of Korea (NRF) 2021M3A9I4023974National Research Foundation of Korea (NRF) 2021M3A9I4027993National Research Foundation of Korea (NRF) RS-2023-00219563
6 · The paper itself

Abstract

The progression of multiple sclerosis (MS) is potentially influenced by the microbiome. Elucidating host-microbiome interactions in MS may aid in developing microbiome-based applications; however, these interactions remain unclear. Here, we aimed to elucidate how Veillonella ratti MHL0042, isolated from human infant feces, modulates neuroinflammation and disease severity in experimental autoimmune encephalomyelitis, a murine MS model. Whole metagenomic sequencing revealed that V. ratti MHL0042 reshaped disrupted gut microbiota via microbial interactions throughout the intestinal tract. V. ratti MHL0042 administration significantly reduced central nervous system inflammation, notably decreasing CD4

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalGastrointestinal MicrobiomeAnimalsDisease Models, AnimalFemaleHumansMiceMicrogliaMultiple SclerosisPhosphatidylethanolaminesPhosphatidylethanolamines

Identifiers

PMID42448967
PMCPMC13434020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.